Cover Image

Repeated intravenous treatment with recombinant tissue-type plasminogen activator in patients with acute ischemic stroke

Increased use of systemic thrombolysis, demographic changes, and higher chances of surviving first-ever strokes all lead to an increasing number of patients with recurrent stroke. However, data on repeated thrombolysis are limited. Here, we report on the safety and clinical effects of repeated intra...

Full description

Saved in:
Bibliographic Details
Main Authors: Laible, Mona (Author) , Jenetzky, Ekkehart (Author) , Möhlenbruch, Markus Alfred (Author) , Ringleb, Peter A. (Author) , Rizos, Timolaos (Author)
Format: Article (Journal)
Language:English
Published: September 11, 2015
In: European neurology
Year: 2015, Volume: 74, Issue: 3/4, Pages: 127-134
ISSN:1421-9913
DOI:10.1159/000439048
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1159/000439048
Verlag, lizenzpflichtig, Volltext: https://www.karger.com/Article/FullText/439048
Get full text
Author Notes:Mona Laible, Ekkehardt Jenetzky, Markus Möhlenbruch, Peter Arthur Ringleb, Timolaos Rizos
Description
Summary:Increased use of systemic thrombolysis, demographic changes, and higher chances of surviving first-ever strokes all lead to an increasing number of patients with recurrent stroke. However, data on repeated thrombolysis are limited. Here, we report on the safety and clinical effects of repeated intravenous recombinant tissue-type plasminogen activator (rt-PA) treatment in a large consecutive cohort of stroke patients.
Item Description:Der Vorname des Verfassers Jenetzky ist falsch geschrieben
Gesehen am 08.06.2020
Physical Description:Online Resource
ISSN:1421-9913
DOI:10.1159/000439048

Similar Items